FL-NCIPHER-SECURITY
17.9.2019 09:03:05 CEST | Business Wire | Press release
nCipher Security, an Entrust Datacard company , announces nShield as a Service , a cloud-based hardware security module (HSM) service that allows organizations to protect sensitive data and applications and helps meet compliance mandates – simply and efficiently, using on-demand cryptography.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190917005391/en/
“Organizations embracing cloud-first strategies require cloud-first encryption,” said Peter Galvin, vice president of strategy, nCipher Security. “This means remote, automated management at scale, and flexible access control both in the cloud and onsite. nShield as a Service makes it easy to adopt a secure, multi-cloud encryption strategy using the same nShield HSMs organizations deploy onsite today.”
nShield as a Service is ideal for cloud-first strategies, selective cloud migration, or adding HSM capacity to handle workload spikes. The customer experience is consistent and familiar – users interact with the cloud-based nShield® HSMs in the same way as with nShield appliances in their own data centers. And customers utilizing nCipher’s unique secure execution environment to run sensitive application code within a secure FIPS-validated boundary now have that same opportunity using cloud-based as well as on premises HSMs.
Using nShield as a Service, customers can:
- implement Bring Your Own Key and Host Your Own Key solutions with a trusted third party service
- maintain full control over key material and maintain separation of data from the encryption keys
- extend cloud-based cryptography and key management across multiple clouds
- implement secure code execution for cloud-based workloads
- integrate with third party applications in the cloud
“The nShield as a Service launch highlights the synergies we’ve gained since becoming an Entrust Datacard company in June,” Galvin said. “We were able to accelerate and enhance nShield as a Service by combining our HSM and cryptography expertise with Entrust Datacard’s experience in data centers, cloud services and HSM operations. The result is a powerful HSM as a service solution that complements the company’s cloud-based PKI and IoT security solutions.”
“Encryption is a powerful tool,” said Robert Westervelt, Research Director, Security Products, IDC. “Delivering it easily across distributed infrastructure can be very effective in protecting data and applications against cyberattacks. Solutions such as nShield as a Service allow even the largest organizations to secure their public cloud workloads with all the conveniences of software-as-a-service offerings. Now, there are no excuses for not using encryption in the cloud.”
How nShield as a Service works
nShield as a Service uses nShield HSMs to generate, access and protect cryptographic key material separately from sensitive data. All nShield HSMs are managed through nCipher’s unique Security World key management architecture that spans cloud-based and on premises HSMs. This lets customers efficiently scale HSM operations while retaining control of their key material, even if they change their cloud service provider.
Organizations can utilize nShield as a Service to supplement or replace on premises HSMs, while keeping the benefits of HSM ownership. The subscription model lets enterprises budget predictably, manage capacity, reduce data center footprint and decrease time spent on routine maintenance and monitoring.
Customers seeking cloud-first solutions can work with market-leading cybersecurity and infrastructure vendors in nCipher’s nFinity Strategic Technology Partner program , including F5, IBM, Micro Focus Voltage, Red Hat and Venafi (see quote sheet below). Applications include SSL/TLS, code signing, data and database encryption and more.
nCipher Security nFinity Strategic Technology Partners talk about nShield as a Service:
F5
“F5 has deep experience in application delivery and security services and helps customers protect their critical applications, ensuring they are safe, secure, and available. The launch of nShield as a Service from nCipher Security gives F5 customers enhanced security choices with the ability to achieve data sovereignty on a subscription-based model. Shifting security from a capital to an operational expenditure enables greater flexibility and cost-effectiveness for organizations,” said John Morgan, VP & GM of Security at F5 Networks.
Rick Robinson, WW Offering Manager, Encryption and Key Management, IBM Security:
“As enterprises increasingly migrate business processes to the cloud, security continues to be a major concern. Ensuring that critical applications and their underpinning cryptographic keys can be protected and managed throughout their lifecycle is vital. The launch of nShield as a Service from nCipher Security gives our joint customers greater choice and the ability to have subscription-based data sovereignty,” said Rick Robinson, WW Offering Manager, Encryption and Key Management, IBM Security.
Micro Focus Voltage
“Data is one of the most abundant and valuable assets for an organization today,” said Reiner Kappenberger, Director Product Management, Voltage Data Security at Micro Focus. “However, without reliable ways to protect data at rest, in motion, and in use, these very assets can become liabilities. As Voltage SecureData customers increasingly migrate storage and workloads to cloud-based environments, they are looking to establish an HSM-based root of trust in the cloud that can maintain the highly available, highly performant data-centric solution they currently enjoy. nShield as a Service from nCipher Security, through its support of Voltage SecureData’s innovative Stateless Key Management, enables Micro Focus to offer its customers continuing relief from the burden of traditional key management in both hybrid and zero data center cloud deployments.”
Red Hat
“As a long-standing nCipher Security nFinity technology partner and the world’s leading provider of open source solutions, Red Hat is committed to providing customers with more choices to enhance. nShield as a Service from nCipher will offer expanded choice to our customers in how they pursue IT security to better protect the underlying cryptographic keys that help to secure Red Hat Certificate System and Red Hat OpenStack Platform deployments across the hybrid cloud,” said Keith Basil, Senior Principal Product Manager at Red Hat.
Venafi
“As the leader in machine identity protection, Venafi welcomes the launch of the new nShield as a Service capability from nCipher Security,” said Kevin Bocek, VP Security Strategy and Threat Intelligence at Venafi. “With the number of machines growing exponentially, and the definition of machines expanding to include everything from containers in Kubernetes clusters running in cloud to embedded IoT devices that will be deployed for the next 20 years, securing machine identities is critical for every business and government. The new nShield as a Service delivers the same robust root of trust that customers have come to depend on with on-premises nShield HSMs, adding a subscription-based security alternative that is easy to use, flexible, and cost-effective for organizations no matter their size. This is an exciting development that will help fast DevOps and security teams move at cloud speed to secure TLS and code signing keys certificates.”
About nCipher Security
nCipher Security, an Entrust Datacard company , is a leader in the general-purpose hardware security module (HSM) market, empowering world-leading organizations by delivering trust, integrity and control to their business-critical information and applications. Today’s fast-moving digital environment enhances customer satisfaction, gives competitive advantage and improves operational efficiency – it also multiplies the security risks. Our cryptographic solutions secure emerging technologies such as cloud, IoT, blockchain, and digital payments and help meet new compliance mandates. We do this using our same proven technology that global organizations depend on today to protect against threats to their sensitive data, network communications and enterprise infrastructure. We deliver trust for your business-critical applications, ensure the integrity of your data and put you in complete control – today, tomorrow, always. www.ncipher.com
Follow us on LinkedIn , Twitter , Facebook and Instagram – search nCipherSecurity.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190917005391/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
